Topics

Decentralized Clinical Trials Among Topics Slated For CDER Guidance In 2020

17:00 EST 2 Feb 2020 | SCRIP

US FDA's to-do list also includes guidances on development of non-opioid analgesics and cannabis compounds, evaluation of generic therapeutic equivalence...

      

Related Stories

 

Original Article: Decentralized Clinical Trials Among Topics Slated For CDER Guidance In 2020

NEXT ARTICLE

More From BioPortfolio on "Decentralized Clinical Trials Among Topics Slated For CDER Guidance In 2020"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...